Evidence map›Paper›PMID 34317246›Full record

ArticleJACC. Case reports2020

Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy.

Weng-Tein Gi, Farbod Sedaghat-Hamedani, Omid Shirvani Samani, Elham Kayvanpour, Esther Herpel, Rawa Arif, Johannes Riffel, Derliz Mereles, Hugo A Katus, Benjamin Meder

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Weng-Tein GiDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.
Farbod Sedaghat-HamedaniDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.
Omid Shirvani SamaniDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.
Elham KayvanpourDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.
Esther HerpelInstitute of Pathology Heidelberg, Heidelberg, Germany.
Rawa ArifDepartment of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany.
Johannes RiffelDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.
Derliz MerelesDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.
Hugo A KatusDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.
Benjamin MederDepartment of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rare case of concomitant hypertrophic cardiomyopathy and cardiac myxoma without LEOPARD syndrome. Additionally, 6 similar cases were systemically reviewed, and the characteristics of this first-ever studied patient group were summarized. (

Indexed as

cardiac myxomaECG, electrocardiogramechocardiographyFO, fossa ovalisHCM, hypertrophic cardiomyopathyhs-cTnT, high-sensitivity cardiac troponin Thypertrophic cardiomyopathyimagingLEOPARD syndromeLGE, late gadolinium enhancementLVOT, left ventricular outflow tractNT-proBNP, N-terminal pro–B-type natriuretic peptideSCD, sudden cardiac death

Identifiers

PMID34317246
PMCPMC8311620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.